Antibacterial development: A changing landscape: Outdated regulatory approaches and company attrition are giving way torenewed interest in antibiotics and innovative ways to evaluate them in the clinic

Microbe

Volumn 11, Issue 3, 2016, Pages 111-118

  Miller, Alita A ^a  

^a Entasis Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84982958041     PISSN: 15587452     EISSN: 15587460     Source Type: Journal    
DOI: 10.1128/microbe.11.111.1     Document Type: Article

References (13)

1. Basarab G et al. 2015. Responding to the challenge of untreatable gonorrhea: ETX0914, a fırst-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. Nature Sci. Rep. 5:11827.
2. Caliendo A et al. 2013. Better tests, better care: improved diagnostics for infectious diseases. Clin. Infect. Dis. 57:Suppl 3.
3. Centers for Disease Control. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/
4. Di Giandomenico A et al. 2014. A multifunctional bispecifıc antibody protects against Pseudomonas aeruginosa. Science Transl. Med. 6:262ra155.
5. European Centre for Disease Prevention and Control/European Medicines Agency. 2009. ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
6. Infectious Diseases Society of America. 2004. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. http://www.idsociety.org/Policy___Advocacy/Antimicrobial_Resistance/Bad_Bugs,_No_Drugs__As_Antibiotic_Discovery_Stagnates,_a_Public_Health_Crisis_Brews/
7. Infectious Diseases Society of America. 2010. The 10’20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 50: 1081-1083.
8. Laxminarayan R et al 2013. Antibiotic resistance - the need for global solutions. Lancet Infect. Dis. 13:1057-1098.
9. O’Neill J. 2015. Securing new drugs for future generations: the pipeline of antibiotics. Review on Antimi-crobial Resistance Report. http://amr-review.org /Publications
10. PCAST 2014 Report to the President on Combating Antibiotic Resistance. https://www.whitehouse.gov/sites/default/fıles/microsites/ostp/PCAST/pcast_carb_report_sept2014.pdf
11. Pucci M, Page M, Bush K. 2014. Cautious optimism for the antibacterial pipeline. Microbe 9:147-152.
12. Rex JH et al. 2013. A comprehensive regulatory frame-work to address the unmet need for new antibacterial treatments. Lancet Infect. Dis. 13:269-275.
13. World Health Organization. Antimicrobial resistance:global report on surveillance 2014 http://www.who.int /drugresistance/documents/surveillancereport/en/